Ivenix CEO Stuart Randle began his foray into drug pump delivery systems at Baxter in 1988, when he led the company’s effort to develop the 1st needle-free IV system. More than 20 years later, when he was approached about the corner office at Ivenix, Randle revisited the infusion pump industry and saw that the technology had not kept up with the changing hospital environment.
“The pumps that are in the marketplace today are like your desktop computer from 10 years or so ago,” Randle told Drug Delivery Business News. “What we’re developing is kind of the iPhone or the Tesla, the current generation of technology for IV infusion.”
Get the full story at our sister site, Drug Delivery Business News
The post Ivenix CEO Randle looks to reboot the infusion pump appeared first on MassDevice.
from MassDevice http://ift.tt/2gxBfw2
Cap comentari:
Publica un comentari a l'entrada